GK Symbio

GK Symbio is a Japanese biotechnology company specializing in regenerative medicine, particularly for dental and periodontal applications. The company was established as a venture from the Tokyo Dental College to commercialize cell sheet technology for the treatment of severe periodontitis. Their lead program involves the use of autologous periodontal ligament-derived cell sheets to regenerate lost periodontal tissue and alveolar bone. By utilizing the patient's own cells, GK Symbio aims to provide a more effective and biological alternative to traditional surgical interventions. The company operates within Japan's specialized regulatory framework for regenerative medicine products. GK Symbio continues to advance its clinical programs to address significant unmet needs in oral healthcare.